Theranostics 2022; 12(10):4603. doi:10.7150/thno.74167 This issue

Erratum

Microenvironment Activatable Nanoprodrug Based on Gripper-like Cyclic Phenylboronic Acid to Precisely and Effectively Alleviate Drug-induced Hepatitis: Erratum

Qixiong Zhang1,*, Corresponding address, Shanshan Li2,*, Lulu Cai1, Yuxuan Zhu1, Xingmei Duan1, Peidu Jiang1, Lei Zhong1, Kun Guo2, Rongsheng Tong1, Corresponding address

1. Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China
2. College of Pharmacy, Southwest Minzu University, Chengdu 610000, China
* These authors contributed equally to this work

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Zhang Q, Li S, Cai L, Zhu Y, Duan X, Jiang P, Zhong L, Guo K, Tong R. Microenvironment Activatable Nanoprodrug Based on Gripper-like Cyclic Phenylboronic Acid to Precisely and Effectively Alleviate Drug-induced Hepatitis: Erratum. Theranostics 2022; 12(10):4603. doi:10.7150/thno.74167. Available from https://www.thno.org/v12p4603.htm

File import instruction

Corrected-article in Theranostics, Volume 11, 8301

 

In the original publication, Figure 8D/H/I/J and Figure 10B/C/D/E showed the MDA, AST, ALT, and LDH levels in APAP-induced acute hepatitis model and RFP-induced chronic hepatitis model, respectively. We are sorry that Figure 10B/C/D/E were presented the same as Figure 8D/H/I/J by mistake. The corrected Figure 10B/C/D/E are shown below. The authors confirm that the correction would not change the result and conclusion of this article. The authors sincerely apologize for any inconvenience or misunderstanding that may have caused.

 Figure 1 

Corrected histograms for the original Figure 10B/C/D/E.

Theranostics Image

(View in new window)

Author contact

Corresponding address Corresponding authors: Qixiong Zhang, PhD, Prof., Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China. E-mail: qixiongzhangcom, zhangqixionguestc.edu.cn (Qixiong Zhang). Rongsheng Tong, PhD, Prof., Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China. E-mail: 2207132448com (Rongsheng Tong)


Published 2022-5-28